GSA CAPITAL PARTNERS LLP - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$311,000
+31.2%
23,006
+86.9%
0.08%
+143.8%
Q3 2019$237,000
-66.9%
12,309
-49.2%
0.03%
-60.0%
Q2 2019$715,000
+93.8%
24,209
+303.5%
0.08%
+300.0%
Q3 2018$369,000
-62.3%
6,000
-63.4%
0.02%
-66.7%
Q4 2017$980,000
+213.1%
16,400
+154.5%
0.06%
+185.7%
Q3 2017$313,000
+21.3%
6,444
+31.3%
0.02%
+23.5%
Q2 2017$258,000
+17.8%
4,906
-60.6%
0.02%
+41.7%
Q2 2016$219,000
-70.1%
12,437
-69.8%
0.01%
-66.7%
Q3 2015$732,00041,2480.04%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
LEVIN CAPITAL STRATEGIES, L.P. 1,373,542$15,658,0001.56%
DAFNA Capital Management LLC 289,040$3,295,0000.87%
Integral Health Asset Management, LLC 250,000$2,850,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 193,266$2,203,0000.80%
PFM Health Sciences, LP 2,182,684$24,883,0000.73%
DCF Advisers, LLC 136,501$1,556,0000.69%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,977,020$33,938,0000.66%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$3,532,0000.61%
Rhenman & Partners Asset Management AB 750,000$8,550,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 1,232,600$14,052,0000.52%
View complete list of AERIE PHARMACEUTICALS INC shareholders